Toxoplasmosis in two cats with inflammatory intestinal disease.
Lymphocytic-plasmacytic enteritis, a chronic inflammatory intestinal disease, was diagnosed in 2 cats. In 1 cat, recurrence of clinical signs after initiating treatment was attributed to relapse of the inflammatory intestinal disease, but was found to be attributable to relapsing toxoplasmosis secondary to immunosuppressive drug therapy. Treatment with clindamycin resolved the recurrent toxoplasmosis. In the second cat, clinical signs of toxoplasmosis did not develop, but serologic testing yielded evidence of active toxoplasmosis. Treatment with clindamycin caused the titers to decrease. Relapsing toxoplasmosis may be responsible for apparent resistance to treatment in cats for inflammatory intestinal disease being treated with immunosuppressive drugs.
Peterson
J L
JL
Department of Small Animal Medicine, Texas A & M University, College Station 77843.
Willard
M D
MD
Lees
G E
GE
Lappin
M R
MR
Dieringer
T
T
Floyd
E
E
D000818:Animals; D000855:Anorexia / Q000662:veterinary; D000913:Antibodies, Protozoan / Q000097:blood; D002371:Cat Diseases / Q000175:diagnosis*; D002415:Cats; D002981:Clindamycin / Q000627:therapeutic use; D003967:Diarrhea / Q000662:veterinary; D004751:Enteritis / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D005260:Female; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007165:Immunosuppression Therapy / Q000662:veterinary; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D014122:Toxoplasma / Q000276:immunology; D014124:Toxoplasmosis, Animal / Q000175:diagnosis* / Q000188:drug therapy; D014839:Vomiting / Q000662:veterinary
D000913:Antibodies, Protozoan; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D002981:Clindamycin; D011239:Prednisolone